New Roche Development Center In Shanghai To Focus on Metabolic Diseases, Tumors
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Roche formally opened its Pharma Development Center in China (PDCC) Oct. 29 in Shanghai, the Swiss company's first comprehensive drug development center in the Asia-Pacific region, outside of Japan